These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. Pacemaker Selection in the Elderly Investigators. Lamas GA, Orav EJ, Stambler BS, Ellenbogen KA, Sgarbossa EB, Huang SK, Marinchak RA, Estes NA, Mitchell GF, Lieberman EH, Mangione CM, Goldman L. N Engl J Med; 1998 Apr 16; 338(16):1097-104. PubMed ID: 9545357 [Abstract] [Full Text] [Related]
3. The Managed Ventricular pacing versus VVI 40 Pacing (MVP) Trial: clinical background, rationale, design, and implementation. Sweeney MO, Ellenbogen KA, Miller EH, Sherfesee L, Sheldon T, Whellan D. J Cardiovasc Electrophysiol; 2006 Dec 16; 17(12):1295-8. PubMed ID: 17081208 [Abstract] [Full Text] [Related]
5. High incidence of pacemaker syndrome in patients with sinus node dysfunction treated with ventricular-based pacing in the Mode Selection Trial (MOST). Link MS, Hellkamp AS, Estes NA, Orav EJ, Ellenbogen KA, Ibrahim B, Greenspon A, Rizo-Patron C, Goldman L, Lee KL, Lamas GA, MOST Study Investigators. J Am Coll Cardiol; 2004 Jun 02; 43(11):2066-71. PubMed ID: 15172414 [Abstract] [Full Text] [Related]
6. Economic and health consequences of managing bradycardia with dual-chamber compared to single-chamber ventricular pacemakers in Italy. Deniz HB, Caro JJ, Ward A, Moller J, Malik F. J Cardiovasc Med (Hagerstown); 2008 Jan 02; 9(1):43-50. PubMed ID: 18268418 [Abstract] [Full Text] [Related]
7. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Sweeney MO, Hellkamp AS, Ellenbogen KA, Greenspon AJ, Freedman RA, Lee KL, Lamas GA, MOde Selection Trial Investigators. Circulation; 2003 Jun 17; 107(23):2932-7. PubMed ID: 12782566 [Abstract] [Full Text] [Related]
9. Cost-effectiveness of dual-chamber pacing compared with ventricular pacing for sinus node dysfunction. Rinfret S, Cohen DJ, Lamas GA, Fleischmann KE, Weinstein MC, Orav J, Schron E, Lee KL, Goldman L. Circulation; 2005 Jan 18; 111(2):165-72. PubMed ID: 15630030 [Abstract] [Full Text] [Related]
10. Prospective randomized study of mode switching in a clinical trial of pacemaker therapy for sinus node dysfunction. Sweeney MO, Hellkamp AS, Ellenbogen KA, Glotzer TV, Silverman R, Yee R, Lee KL, Lamas GA, MOST Investigators. J Cardiovasc Electrophysiol; 2004 Feb 18; 15(2):153-60. PubMed ID: 15028043 [Abstract] [Full Text] [Related]
11. Treatment crossovers did not affect randomized treatment comparisons in the Mode Selection Trial (MOST). Hellkamp AS, Lee KL, Sweeney MO, Link MS, Lamas GA, MOST Investigators. J Am Coll Cardiol; 2006 Jun 06; 47(11):2260-6. PubMed ID: 16750693 [Abstract] [Full Text] [Related]
12. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials. Wilkoff BL, Dual Chamber and VVI Implantable Defibrillator trial investigators. Card Electrophysiol Rev; 2003 Dec 06; 7(4):468-72. PubMed ID: 15071277 [Abstract] [Full Text] [Related]
13. Atrial fibrillation and quality of life after pacemaker implantation for sick sinus syndrome: data from the Mode Selection Trial (MOST). Fleischmann KE, Orav EJ, Lamas GA, Mangione CM, Schron EB, Lee KL, Goldman L, MOST investigators. Am Heart J; 2009 Jul 06; 158(1):78-83.e2. PubMed ID: 19540395 [Abstract] [Full Text] [Related]
14. Death in patients with permanent pacemakers for sick sinus syndrome. Flaker G, Greenspon A, Tardiff B, Schron E, Goldman L, Hellkamp A, Lee K, Lamas G, Mode Selection Trial (MOST) Investigators. Am Heart J; 2003 Nov 06; 146(5):887-93. PubMed ID: 14597940 [Abstract] [Full Text] [Related]
15. Clinical and quality of life comparison of accelerometer, piezoelectric crystal, and blended sensors in DDDR-paced patients with sinus node dysfunction in the mode selection trial (MOST). Shukla HH, Flaker GC, Hellkamp AS, James EA, Lee KL, Goldman L, Orav EJ, Lamas GA. Pacing Clin Electrophysiol; 2005 Aug 06; 28(8):762-70. PubMed ID: 16105001 [Abstract] [Full Text] [Related]
16. Electrophysiological determinants of atrial fibrillation in sinus node dysfunction despite atrial pacing. De Sisti A, Attuel P, Manot S, Fiorello P, Halimi F, Leclercq JF. Europace; 2000 Oct 06; 2(4):304-11. PubMed ID: 11194597 [Abstract] [Full Text] [Related]
17. DDD versus VVIR versus VVI mode in patients with indication to dual-chamber stimulation: a prospective, randomized, controlled, single-blind study. Moro E, Caprioglio F, Berton G, Marcon C, Riva U, Corbucci G, Delise P. Ital Heart J; 2005 Sep 06; 6(9):728-33. PubMed ID: 16212074 [Abstract] [Full Text] [Related]
18. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. Lamas GA, Lee KL, Sweeney MO, Silverman R, Leon A, Yee R, Marinchak RA, Flaker G, Schron E, Orav EJ, Hellkamp AS, Greer S, McAnulty J, Ellenbogen K, Ehlert F, Freedman RA, Estes NA, Greenspon A, Goldman L, Mode Selection Trial in Sinus-Node Dysfunction. N Engl J Med; 2002 Jun 13; 346(24):1854-62. PubMed ID: 12063369 [Abstract] [Full Text] [Related]
19. Reduced ejection fraction, sudden cardiac death, and heart failure death in the mode selection trial (MOST): implications for device selection in elderly patients with sinus node disease. Sweeney MO, Hellkamp AS, Ellenbogen KA, Lamas GA. J Cardiovasc Electrophysiol; 2008 Nov 13; 19(11):1160-6. PubMed ID: 18554201 [Abstract] [Full Text] [Related]
20. A comparison of single-lead atrial pacing with dual-chamber pacing in sick sinus syndrome. Nielsen JC, Thomsen PE, Højberg S, Møller M, Vesterlund T, Dalsgaard D, Mortensen LS, Nielsen T, Asklund M, Friis EV, Christensen PD, Simonsen EH, Eriksen UH, Jensen GV, Svendsen JH, Toff WD, Healey JS, Andersen HR, DANPACE Investigators. Eur Heart J; 2011 Mar 13; 32(6):686-96. PubMed ID: 21300730 [Abstract] [Full Text] [Related] Page: [Next] [New Search]